SherpaBonds
US78081BAV53 · Corp · USDInvestment Grade · Baa2

Royalty Pharma Plc 5.95% 2055/09

Royalty Pharma PlcUnited StatesGLOBALSenior Unsecured
SHARE
▶ Start radio
MID PRICE
98.83
par = 100
YIELD TO MAT.
6.04%
semi-annual
COUPON
5.950%
semi-annual · fixed
MATURITY
2055-09-25
bullet · 29.38y
OUTSTANDING
—
not disclosed
AS OF
2026-05-07

Sign up free to see prices on this bond

Free accounts get 40 bond price views per month — 4× the anonymous quota. Pro is unlimited.

Sign inSign up free

About this bond

AI BRIEF · GROUNDED IN STRUCTURED DATA
About the issuer

Royalty Pharma is a private equity investor firm founded in 1996. It purchases the rights to royalties on future drug sales. It claims to own partial rights to 7 of the top 30 selling drugs in the United States.

Source: Wikipedia →

Risk analytics

SEMI-ANNUAL · BULLET · PAR 100
Modified duration
13.62 y
1bp ↑ ≈ -0.136% P&L
Convexity
287.77
higher = more curvature
Years to maturity
29.38 y
YTM source
Ingested
Market signals · funds disclosing this bond
SignalCategoryExposureLast moveWeightAs of
iShares Core U.S. Aggregate Bond
iShares
US Aggregate$2.4M▼ $14K0.00%2026-05-07
iShares Broad USD Investment Grade Corporate Bond
iShares
US Broad IG Corporate$980K▼ $5K0.01%2026-05-07
SPDR DoubleLine Total Return Tactical
SPDR
US Active Aggregate$773K▲ $8K0.02%2026-05-05
iShares Core Universal USD Bond
iShares
US Aggregate$472K▼ $3K0.00%2026-05-07
iShares 10+ Year Investment Grade Corporate Bond
iShares
US IG Corporate$408K▼ $2K0.02%2026-05-07
SPDR Portfolio Long Term Corporate Bond
SPDR
US IG Corporate Long$291K▼ $86K0.02%2026-05-05
SPDR Portfolio Aggregate Bond
SPDR
US Aggregate$222K▲ $2K0.00%2026-05-05
SPDR Portfolio Corporate Bond
SPDR
US IG Corporate$163K▲ $1K0.01%2026-05-05
iShares ESG Aware USD Corporate Bond
iShares
US ESG IG Corporate$114K▼ $6980.01%2026-05-07
iShares ESG Aware U.S. Aggregate Bond
iShares
US ESG Aggregate$75K▼ $4550.00%2026-05-07
iShares Core 10+ Year USD Bond
iShares
US Aggregate$50K▼ $3040.01%2026-05-07
iShares Interest Rate Hedged Long-Term Corporate Bond
iShares
US IG Corporate Hedged$24K▼ $1320.01%2026-05-07
iShares Interest Rate Hedged U.S. Aggregate Bond
iShares
US Aggregate$84—0.00%2026-05-07
Subscribe to reveal which signals are holding this bond.Subscribe →

Price history

Sherpa Signal

AS OF 2026-05-07

Institutional footprint · signal-level holdings

37/ 100Early footprint
Interpretation. Light institutional footprint, with net distribution
HOLDERS
13
▲ 1 signal in 7d
AGGREGATE EXPOSURE
$5.9M
USD across all
TOP CONCENTRATION
39.7%
largest holder
FLOW
▼ $546K
▲ 1 signal in 7d

Sherpa Signal is derived from a panel of tracked institutional portfolios. Names of individual holders are not disclosed.

100K PAR NOTIONAL · MARKET VALUE
98,830 USD
PRICE
98.83

RFQ routing · coming soon

Security details

VIA OPENFIGI
Canonical
RPRX 5.95 09/25/55
FIGI
BBG01X0X8FW6
CUSIP
78081BAV5
ISIN
US78081BAV53
Type
Corp
Issued
2025-09-16
Face value
100 USD
Ticker
RPRX 5.95 09/25/55
Sec. type
GLOBAL
Seniority
Senior Unsecured

Issuer curve

RPRX · 10 PTS

Yield (%) plotted against years-to-maturity. This bond highlighted in amber.

Bonds like this

HEURISTIC

Same currency & sector, maturity within 7 years. Ranked by overlapping institutional owners, issuer match, and rating distance.

Royalty Pharma Plc 5.9% 09/2054
Royalty Pharma Plc
2054-09
6.01%
−3 bps yield−1y duration9 signals in commonSame issuer
Royalty Pharma Plc 3.35% 09/2051
Royalty Pharma Plc
2051-09
5.95%
−9 bps yield−4y duration8 signals in commonSame issuer
Royalty Pharma Plc 5.4% 09/2034
Royalty Pharma Plc
2034-09
5.20%
−84 bps yield−21y duration6 signals in commonSame issuer
Royalty Pharma Plc 3.55% 09/2050
Royalty Pharma Plc
2050-09
6.00%
−4 bps yield−5y duration8 signals in commonSame issuer
Royalty Pharma Plc 5.2% 09/2035
Royalty Pharma Plc
2035-09
5.28%
−76 bps yield−20y duration5 signals in commonSame issuer
Royalty Pharma Plc 4.45% 03/2031
Royalty Pharma Plc
2031-03
4.73%
−131 bps yield−25y duration5 signals in commonSame issuer